BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies

BCL-2 overexpression has been associated with resistance to chemotherapy and reduced survival in acute myeloid leukemia (AML), but few data are available in elderly patients, a subset accounting for majority of AML cases and with dismal prognosis. We retrospectively analyzed 113 AML patients aged ≥6...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiribelli, Mario, Michelutti, Angela, Cavallin, Margherita, Di Giusto, Sara, Simeone, Erica, Fanin, Renato, Damiani, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585096/
https://www.ncbi.nlm.nih.gov/pubmed/34768616
http://dx.doi.org/10.3390/jcm10215096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585096/
https://www.ncbi.nlm.nih.gov/pubmed/34768616
http://dx.doi.org/10.3390/jcm10215096

Ejemplares similares